Celltrion Pharm Stock Forecast - Naive Prediction

068760 Stock  KRW 59,800  1,300  2.13%   
The Naive Prediction forecasted value of Celltrion Pharm on the next trading day is expected to be 63,448 with a mean absolute deviation of 1,618 and the sum of the absolute errors of 98,703. Celltrion Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Celltrion Pharm stock prices and determine the direction of Celltrion Pharm's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Celltrion Pharm's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
A naive forecasting model for Celltrion Pharm is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Celltrion Pharm value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Celltrion Pharm Naive Prediction Price Forecast For the 23rd of December

Given 90 days horizon, the Naive Prediction forecasted value of Celltrion Pharm on the next trading day is expected to be 63,448 with a mean absolute deviation of 1,618, mean absolute percentage error of 4,107,631, and the sum of the absolute errors of 98,703.
Please note that although there have been many attempts to predict Celltrion Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Celltrion Pharm's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Celltrion Pharm Stock Forecast Pattern

Backtest Celltrion PharmCelltrion Pharm Price PredictionBuy or Sell Advice 

Celltrion Pharm Forecasted Value

In the context of forecasting Celltrion Pharm's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Celltrion Pharm's downside and upside margins for the forecasting period are 63,445 and 63,451, respectively. We have considered Celltrion Pharm's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
59,800
63,445
Downside
63,448
Expected Value
63,451
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Celltrion Pharm stock data series using in forecasting. Note that when a statistical model is used to represent Celltrion Pharm stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria133.3389
BiasArithmetic mean of the errors None
MADMean absolute deviation1618.0818
MAPEMean absolute percentage error0.0278
SAESum of the absolute errors98702.9892
This model is not at all useful as a medium-long range forecasting tool of Celltrion Pharm. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Celltrion Pharm. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Celltrion Pharm

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Celltrion Pharm. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
59,79759,80059,803
Details
Intrinsic
Valuation
LowRealHigh
50,39750,40065,780
Details
Bollinger
Band Projection (param)
LowMiddleHigh
49,30356,51563,727
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Celltrion Pharm. Your research has to be compared to or analyzed against Celltrion Pharm's peers to derive any actionable benefits. When done correctly, Celltrion Pharm's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Celltrion Pharm.

Other Forecasting Options for Celltrion Pharm

For every potential investor in Celltrion, whether a beginner or expert, Celltrion Pharm's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Celltrion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Celltrion. Basic forecasting techniques help filter out the noise by identifying Celltrion Pharm's price trends.

Celltrion Pharm Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celltrion Pharm stock to make a market-neutral strategy. Peer analysis of Celltrion Pharm could also be used in its relative valuation, which is a method of valuing Celltrion Pharm by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Celltrion Pharm Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Celltrion Pharm's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Celltrion Pharm's current price.

Celltrion Pharm Market Strength Events

Market strength indicators help investors to evaluate how Celltrion Pharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Celltrion Pharm shares will generate the highest return on investment. By undertsting and applying Celltrion Pharm stock market strength indicators, traders can identify Celltrion Pharm entry and exit signals to maximize returns.

Celltrion Pharm Risk Indicators

The analysis of Celltrion Pharm's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Celltrion Pharm's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting celltrion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Celltrion Pharm

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Celltrion Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celltrion Pharm will appreciate offsetting losses from the drop in the long position's value.

Moving together with Celltrion Stock

  0.77005935 Samsung ElectronicsPairCorr

Moving against Celltrion Stock

  0.84122870 YG EntertainmentPairCorr
  0.8041510 SM EntertainmentPairCorr
  0.75003535 Hanwha InvestmentSecuriPairCorr
  0.73012330 Hyundai MobisPairCorr
  0.69032640 LG UplusPairCorr
The ability to find closely correlated positions to Celltrion Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Celltrion Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Celltrion Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Celltrion Pharm to buy it.
The correlation of Celltrion Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Celltrion Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Celltrion Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Celltrion Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Celltrion Stock

Celltrion Pharm financial ratios help investors to determine whether Celltrion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Celltrion with respect to the benefits of owning Celltrion Pharm security.